FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Ian Critchley

Research Profile

Procedures

Living Beings

Chemicals & Drugs

Physiology

Geographic Areas

Disorders

Co-author Network

Publications

TOP 3
Mark E Jones; J Goguen; Ian A Critchley; Deborah C Draghi; James A Karlowsky; Daniel F Sahm; R Porschen; Guy Patra; Vito G DelVecchio
Antibiotic susceptibility of isolates of Bacillus anthracis, a bacterial pathogen with the potential to be used in biowarfare.
Mark E Jones; Renée S Blosser-Middleton; Ian A Critchley; James A Karlowsky; Clyde Thornsberry; Daniel F Sahm
In vitro susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis: a European multicenter study during 2000-2001.
James A Karlowsky; Clyde Thornsberry; Ian A Critchley; Mark E Jones; Alan T Evangelista; Gary J Noel; Daniel F Sahm
Susceptibilities to levofloxacin in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis clinical isolates from children: results from 2000-2001 and 2001-2002 TRUST studies in the United States.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Ian Critchley (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2003: Mark E Jones; J Goguen; Ian A Critchley; Deborah C Draghi; James A Karlowsky; Daniel F Sahm; R Porschen; Guy Patra; Vito G DelVecchio
Antibiotic susceptibility of isolates of Bacillus anthracis, a bacterial pathogen with the potential to be used in biowarfare.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2003;9(9):984-6.
2003: Mark E Jones; Renée S Blosser-Middleton; Ian A Critchley; James A Karlowsky; Clyde Thornsberry; Daniel F Sahm
In vitro susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis: a European multicenter study during 2000-2001.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2003;9(7):590-9.
2003: James A Karlowsky; Clyde Thornsberry; Ian A Critchley; Mark E Jones; Alan T Evangelista; Gary J Noel; Daniel F Sahm
Susceptibilities to levofloxacin in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis clinical isolates from children: results from 2000-2001 and 2001-2002 TRUST studies in the United States.
Antimicrobial agents and chemotherapy 2003;47(6):1790-7.
2003: Renée S Blosser-Middleton; Daniel F Sahm; Clyde Thornsberry; Mark E Jones; P A Hogan; Ian A Critchley; James A Karlowsky
Antimicrobial susceptibility of 840 clinical isolates of Haemophilus influenzae collected in four European countries in 2000-2001.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2003;9(5):431-6.
2003: Ian A Critchley; Daniel F Sahm; Laurie J Kelly; James A Karlowsky
In vitro synergy studies using aztreonam and fluoroquinolone combinations against six species of Gram-negative bacilli.
Chemotherapy 2003;49(1-2):44-8.
2003: Ian A Critchley; Renée S Blosser-Middleton; Mark E Jones; Clyde Thornsberry; Daniel F Sahm; James A Karlowsky
Baseline study to determine in vitro activities of daptomycin against gram-positive pathogens isolated in the United States in 2000-2001.
Antimicrobial agents and chemotherapy 2003;47(5):1689-93.
2003: James A Karlowsky; Clyde Thornsberry; Mark E Jones; Alan T Evangelista; Ian A Critchley; Daniel F Sahm
Factors associated with relative rates of antimicrobial resistance among Streptococcus pneumoniae in the United States: results from the TRUST Surveillance Program (1998-2002).
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2003;36(8):963-70.
2003: Ian A Critchley; Deborah C Draghi; Daniel F Sahm; Clyde Thornsberry; Mark E Jones; James A Karlowsky
Activity of daptomycin against susceptible and multidrug-resistant Gram-positive pathogens collected in the SECURE study (Europe) during 2000-2001.
The Journal of antimicrobial chemotherapy 2003;51(3):639-49.
2003: Mark E Jones; James A Karlowsky; Renée S Blosser-Middleton; Ian A Critchley; Elena Karginova; Clyde Thornsberry; Daniel F Sahm
Reinterpretation of susceptibility data using current NCCLS breakpoint criteria.
Antimicrobial agents and chemotherapy 2003;47(2):830.
2003: Mark E Jones; Renée S Blosser-Middleton; Ian A Critchley; James A Karlowsky; Clyde Thornsberry; Daniel F Sahm
Activity of faropenem, a new furanem, against European respiratory pathogens collected during 2000-2001: a comparison with other beta-lactam agents.
The Journal of antimicrobial chemotherapy 2003;51(1):196-9.
2002: Mark E Jones; Renée S Blosser-Middleton; Ian A Critchley; Clyde Thornsberry; Daniel F Sahm; Juri Yamakita; Moriaki Akasaki; James A Karlowsky
The activity of levofloxacin and comparator agents against clinical isolates of Streptococcus pneumoniae collected worldwide during 1999 and 2000.
Chemotherapy 2002;48(5):232-7.
2002: Mark E Jones; James A Karlowsky; Renée S Blosser-Middleton; Ian A Critchley; Clyde Thornsberry; Daniel F Sahm
Relationship between antibiotic resistance in Streptococcus pneumoniae and that in Haemophilus influenzae: evidence for common selective pressure.
Antimicrobial agents and chemotherapy 2002;46(9):3106-7.
2002: Ian A Critchley; Renée S Blosser-Middleton; Mark E Jones; James A Karlowsky; Elena Karginova; Clyde Thornsberry; Daniel F Sahm
Phenotypic and genotypic analysis of levofloxacin-resistant clinical isolates of Streptococcus pneumoniae collected in 13 countries during 1999-2000.
International journal of antimicrobial agents 2002;20(2):100-7.
2002: James A Karlowsky; Deborah C Draghi; Clyde Thornsberry; Mark E Jones; Ian A Critchley; Daniel F Sahm
Antimicrobial susceptibilities of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in two successive respiratory seasons in the US.
International journal of antimicrobial agents 2002;20(2):76-85.
2002: Mark E Jones; James A Karlowsky; Renée S Blosser-Middleton; Ian A Critchley; Elena Karginova; Clyde Thornsberry; Daniel F Sahm
Longitudinal assessment of antipneumococcal susceptibility in the United States.
Antimicrobial agents and chemotherapy 2002;46(8):2651-5.
2002: James A Karlowsky; Laurie J Kelly; Ian A Critchley; Mark E Jones; Clyde Thornsberry; Daniel F Sahm
Determining Linezolid's baseline in vitro activity in Canada using gram-positive clinical isolates collected prior to its national release.
Antimicrobial agents and chemotherapy 2002;46(6):1989-92.
2002: Mark E Jones; Ian A Critchley; James A Karlowsky; Renée S Blosser-Middleton; Franz-Josef Schmitz; Clyde Thornsberry; Daniel F Sahm
In vitro activities of novel nonfluorinated quinolones PGE 9262932 and PGE 9509924 against clinical isolates of Staphylococcus aureus and Streptococcus pneumoniae with defined mutations in DNA gyrase and topoisomerase IV.
Antimicrobial agents and chemotherapy 2002;46(6):1651-7.
2002: Ian A Critchley; M E Jones; PD Heinze; D Hubbard; H D Engler; A T Evangelista; Clyde Thornsberry; J A Karlowsky; D F Sahm
In vitro activity of levofloxacin against contemporary clinical isolates of Legionella pneumophila, Mycoplasma pneumoniae and Chlamydia pneumoniae from North America and Europe.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2002;8(4):214-21.
2002: Ian A Critchley; Renée S Blosser-Middleton; Mark E Jones; Juri Yamakita; N Aswapokee; Pantip Chayakul; P Tharavichitukul; A Vibhagool; Clyde Thornsberry; James A Karlowsky; Daniel F Sahm
Antimicrobial resistance among respiratory pathogens collected in Thailand during 1999-2000.
Journal of chemotherapy (Florence, Italy) 2002;14(2):147-54.
2002: James A Karlowsky; Ian A Critchley; Renée S Blosser-Middleton; Elena Karginova; Mark E Jones; Clyde Thornsberry; Daniel F Sahm
Antimicrobial surveillance of Haemophilus influenzae in the United States during 2000-2001 leads to detection of clonal dissemination of a beta-lactamase-negative and ampicillin-resistant strain.
Journal of clinical microbiology 2002;40(3):1063-6.
2002: Clyde Thornsberry; Daniel F Sahm; Laurie J Kelly; Ian A Critchley; Mark E Jones; Alan T Evangelista; James A Karlowsky
Regional trends in antimicrobial resistance among clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States: results from the TRUST Surveillance Program, 1999-2000.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2002;34 Suppl 1():S4-S16.
2002: Mark E Jones; Giovanni Gesu; G Ortisi; Daniel F Sahm; Ian A Critchley; A Goglio
Proficiency of Italian clinical laboratories in detecting reduced glycopeptide susceptibility in Enterococcus and Staphylococcus spp. using routine laboratory methodologies.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2002;8(2):101-11.
2002: Ian A Critchley; Daniel F Sahm; Clyde Thornsberry; Renée S Blosser-Middleton; Mark E Jones; James A Karlowsky
Antimicrobial susceptibilities of Streptococcus pyogenes isolated from respiratory and skin and soft tissue infections: United States LIBRA surveillance data from 1999.
Diagnostic microbiology and infectious disease 2002;42(2):129-35.
2002: Mark E Jones; James A Karlowsky; Renée S Blosser-Middleton; Ian A Critchley; Clyde Thornsberry; Daniel F Sahm
Apparent plateau in beta-lactamase production among clinical isolates of Haemophilus influenzae and Moraxella catarrhalis in the United States: results from the LIBRA Surveillance initiative.
International journal of antimicrobial agents 2002;19(2):119-23.
2002: Ian A Critchley; James A Karlowsky; Deborah C Draghi; Mark E Jones; Clyde Thornsberry; Kate Murfitt; Daniel F Sahm
Activities of faropenem, an oral beta-lactam, against recent U.S. isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis.
Antimicrobial agents and chemotherapy 2002;46(2):550-5.
2002: James A Karlowsky; Mark E Jones; Deborah C Draghi; Ian A Critchley; Clyde Thornsberry; Daniel F Sahm
In vitro susceptibility of recent clinical isolates of pneumococci to the investigational cephalosporin cefditoren.
Diagnostic microbiology and infectious disease 2002;42(1):59-64.
2002: James A Karlowsky; Ian A Critchley; Deborah C Draghi; Mark E Jones; Clyde Thornsberry; Daniel F Sahm
Activity of cefditoren against beta-lactamase-positive and -negative Haemophilus influenzae and Moraxella catarrhalis.
Diagnostic microbiology and infectious disease 2002;42(1):53-8.
2002: James A Karlowsky; Laurie J Kelly; Clyde Thornsberry; Mark E Jones; Alan T Evangelista; Ian A Critchley; Daniel F Sahm
Susceptibility to fluoroquinolones among commonly isolated Gram-negative bacilli in 2000: TRUST and TSN data for the United States. Tracking Resistance in the United States Today. The Surveillance Network.
International journal of antimicrobial agents 2002;19(1):21-31.
2001: Ian A Critchley; R S Blosser; James A Karlowsky; Juri Yamakita; A Barth; Helio S Sader; C Mendes; L Teixeira; F Rossi; C A Dias; Mark E Jones; Clyde Thornsberry; Daniel F Sahm
Antimicrobial resistance in respiratory pathogens isolated in Brazil during 1999-2000.
The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 2001;5(6):294-304.
2001: Clyde Thornsberry; James A Karlowsky; Laurie J Kelly; Deborah C Draghi; Ian A Critchley; Mark E Jones; Daniel F Sahm
Comparative activity of cefditoren and other oral beta-lactams against nonpneumococcal streptococci.
Chemotherapy 2001;47(5):332-43.
2001: James A Karlowsky; Mark E Jones; Clyde Thornsberry; Ian A Critchley; Laurie J Kelly; Daniel F Sahm
Prevalence of antimicrobial resistance among urinary tract pathogens isolated from female outpatients across the US in 1999.
International journal of antimicrobial agents 2001;18(2):121-7.
2001: Daniel F Sahm; James A Karlowsky; Laurie J Kelly; Ian A Critchley; Mark E Jones; Clyde Thornsberry; YR Mauriz; J Kahn
Need for annual surveillance of antimicrobial resistance in Streptococcus pneumoniae in the United States: 2-year longitudinal analysis.
Antimicrobial agents and chemotherapy 2001;45(4):1037-42.
2001: Daniel F Sahm; Ian A Critchley; Laurie J Kelly; James A Karlowsky; David C Mayfield; Clyde Thornsberry; YR Mauriz; J Kahn
Evaluation of current activities of fluoroquinolones against gram-negative bacilli using centralized in vitro testing and electronic surveillance.
Antimicrobial agents and chemotherapy 2001;45(1):267-74.
2000: M E Jones; A M Staples; Ian A Critchley; Clyde Thornsberry; PD Heinze; H D Engler; D F Sahm
Benchmarking the in vitro activities of moxifloxacin and comparator agents against recent respiratory isolates from 377 medical centers throughout the United States.
Antimicrobial agents and chemotherapy 2000;44(10):2645-52.
2000: M E Jones; A M Staples; Ian A Critchley; Clyde Thornsberry; PD Heinze; H D Engler; D F Sahm
Benchmarking the in vitro activity of moxifloxacin against recent isolates of Streptococcus pneumoniae, Moraxella catarrhalis, and Haemophilus influenzae. A European multi-centre study.
Diagnostic microbiology and infectious disease 2000;37(3):203-11.
2000: Ian A Critchley; Clyde Thornsberry; G Piazza; M Jones; ML Hickey; A L Barth; C Mendes; F F Rossi; Helio S Sader; Lucia Martins Teixeira; Daniel F Sahm
Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis collected from five centers in Brazil, 1997-98.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2000;6(4):178-84.